A Study of BBI608 in Adult Patients With Advanced Malignancies

NCT01775423 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

87

Enrollment

INDUSTRY

Sponsor class

Conditions

Cancer, Advanced Malignancies

Interventions

DRUG: BBI608

Sponsor

Sumitomo Pharma America, Inc.